Egetis Therapeutics AB (publ)

BATS-CHIXE:EGTXS Stock Report

Market Cap: SEK 1.3b

Egetis Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

BATS-CHIXE:EGTXS Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
09 Jan 25SellSEK 1,431,249Yilmaz MahshidIndividual213,089SEK 6.82
08 Nov 24BuySEK 25,020Christian SonessonIndividual6,000SEK 4.22
08 Nov 24BuySEK 280,150Henrik KrookIndividual65,000SEK 4.31
07 Oct 24BuySEK 42,250Yilmaz MahshidIndividual10,000SEK 4.23
07 Oct 24BuySEK 43,103Nicklas WesterholmIndividual10,142SEK 4.25

Insider Trading Volume

Insider Buying: EGTXS insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of EGTXS?
Owner TypeNumber of SharesOwnership Percentage
VC/PE Firms38,675,50113.2%
Individual Insiders47,988,32816.4%
Private Companies61,976,21121.2%
Institutions66,767,60522.8%
General Public77,163,81426.4%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 17.2%.

Top Shareholders

Top 25 shareholders own 73.57% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
13.2%
Frazier Life Sciences Management, LP
38,675,501SEK 177.7m0%0.7%
11.5%
Cetoros AB
33,776,221SEK 155.2m0%no data
10.3%
Peter Lindell
30,007,682SEK 137.9m0%no data
7.32%
Fourth Swedish National Pension Fund (AP4)
21,404,690SEK 98.4m0%0.04%
6.04%
Avla Holding AB
17,668,330SEK 81.2m0%no data
4.73%
Flerie AB (publ)
13,844,458SEK 63.6m0%9.31%
4.61%
Thomas Eldered
13,499,458SEK 62.0m0%no data
4.04%
Handelsbanken Asset Management
11,831,897SEK 54.4m0%0.01%
3.6%
Recipharm AB (publ)
10,531,660SEK 48.4m0%no data
2.57%
Linc AB
7,532,021SEK 34.6m0%1.63%
2.37%
Unionen, Endowment Arm
6,946,793SEK 31.9m0%0.91%
1.07%
Mats Blom
3,134,762SEK 14.4m0%no data
0.52%
SEB Investment Management AB
1,519,937SEK 7.0m0%no data
0.39%
Healthinvest Partners AB
1,129,177SEK 5.2m0%0.19%
0.34%
Swedbank Robur Fonder AB
1,000,000SEK 4.6m0%no data
0.26%
FCG Fonder AB
772,249SEK 3.5m0%0.04%
0.12%
Henrik Krook
339,593SEK 1.6m0%no data
0.11%
Yilmaz Mahshid
313,089SEK 1.4m3.3%no data
0.11%
Financiere Arbevel
310,000SEK 1.4m0%0.03%
0.097%
Thomas Lonngren
283,158SEK 1.3m0%no data
0.086%
Avanza Fonder AB
250,662SEK 1.2m26.2%no data
0.083%
Nicklas Westerholm
242,718SEK 1.1m4.36%no data
0.042%
Skandia Fonder AB
121,862SEK 559.9k0%no data
0.025%
Storebrand Fonder AB,
73,895SEK 339.6k0%no data
0.014%
Gunilla Osswald
40,000SEK 183.8k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/10/15 19:16
End of Day Share Price 2024/07/18 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Egetis Therapeutics AB (publ) is covered by 10 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
null nullABG Sundal Collier
Patrick LangstromABG Sundal Collier Sponsored
Oscar Haffen LammBryan Garnier & Co